Title:
PYRAZOLOPYRIMIDINE COMPOUND
Document Type and Number:
WIPO Patent Application WO/2014/030716
Kind Code:
A1
Abstract:
Provided is a pyrazolopyrimidine compound represented by formula (I) having an HIF-PHD inhibitory effect, or a pharmaceutically acceptable salt thereof. [In the formula, AA indicates an optionally substituted 7-hydroxypyrazolo[4,3-d]pyrimidine-5-yl, X indicates a simple bond or an optionally substituted straight-chain alkylene, Z indicates hydrogen atom, or formula (i), formula (ii) or formula (iii), and rings A and A' are independently an optionally substituted aryl, an optionally substituted heteroaryl, an optionally substituted alicyclic hydrocarbon, or an optionally substituted non-aromatic heterocycle.]
Inventors:
NAKAJIMA TATSUO (JP)
GOI TAKASHI (JP)
KAWATA ATSUSHI (JP)
SUGAHARA MASAKATSU (JP)
YAMAKOSHI SHUHEI (JP)
GOI TAKASHI (JP)
KAWATA ATSUSHI (JP)
SUGAHARA MASAKATSU (JP)
YAMAKOSHI SHUHEI (JP)
Application Number:
PCT/JP2013/072461
Publication Date:
February 27, 2014
Filing Date:
August 22, 2013
Export Citation:
Assignee:
MITSUBISHI TANABE PHARMA CORP (JP)
International Classes:
C07D487/04; A61K31/519; A61P3/10; A61P7/02; A61P7/06; A61P9/10; A61P25/14; A61P25/16; A61P25/28; A61P43/00
Foreign References:
| JP2012517473A | 2012-08-02 | |||
| JP2011519857A | 2011-07-14 | |||
| JPH0641133A | 1994-02-15 |
Other References:
WARSHAKOON,N.C. ET AL., BIOORG.MED.CHEM.LETT., vol. 16, no. 21, 1 November 2006 (2006-11-01), pages 5687 - 5690
Attorney, Agent or Firm:
SAMEJIMA, Mutsumi et al. (JP)
Mutsumi Sameshima (JP)
Mutsumi Sameshima (JP)
Download PDF: